Archived research. Equity forecasting is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive
Back to Forecasting
ADMA Forecast Markets
ADMA Biologics
7
Active Markets
45%
Avg Probability
All Markets
7 markets
Will ADMA's days sales outstanding (DSO) remain above 90 days through H1 2026?
57%
Likely Yes
94% agreement
Aug 15, 2026
IG: 0.80
Will ADMA report Q1 2026 revenue above $130M?
75%
Likely Yes
94% agreement
May 15, 2026
IG: 0.64
Will McKesson account for more than 15% of ADMA's revenue by Q4 2026?
25%
Likely No
94% agreement
Mar 15, 2027
IG: 0.64
Will ADMA disclose an SEC formal investigation by year-end 2026?
16%
Likely No
96% agreement
Dec 31, 2026
IG: 0.60
Will ADMA achieve FY2026 revenue above $635M?
58%
Likely Yes
92% agreement
Mar 15, 2027
IG: 0.60
Will CEO Grossman become a net seller of ADMA shares by year-end 2026?
23%
Likely No
94% agreement
Jan 31, 2027
IG: 0.48
Will ADMA's FY2026 gross margin exceed 60%?
62%
Likely Yes
94% agreement
Mar 15, 2027
IG: 0.48
Resolution Timeline
Aug 15, 2026
Will ADMA's days sales outstanding (DSO) remain above 90 days through H1 2026?Prediction: 57%